P3.01-075 Afatinib Dose Adjustment: Effect on Safety, Efficacy and Patient-Reported Outcomes in the LUX-Lung 3/6 Trials in EGFRm+ NSCLC
Vera Hirsh,Eng-Huat Tan,Y. Wu,Lecia V. Sequist,C. Zhou,Martin Schuler,Sarayut Lucien Geater,T. Mok,Chunhong Hu,Nobuyuki Yamamoto,Jifeng Feng,Kenneth J. O’Byrne,Shunyuan Lu,Y. Huang,Martin Sebastian,Isamu Okamoto,N. Dickgreber,Riyaz Shah,Michael K. Palmer,A. Märten,Dan Massey,C. Samuelsen,James Chih-Hsin Yang JOURNAL OF THORACIC ONCOLOGY（2017）
关键词
dose adjustment,PROs,afatinib
AI 理解论文
溯源树
样例
